What does it really take to move scientific innovation out of the lab and into the real world?
In this episode of Innovate Together, Matt Freeman sits down with Neciah Dorh, CEO at FluoretiQ — a company developing next-generation diagnostic technology designed to detect infections earlier, faster and more accurately.
Together, they explore the journey from research to commercialisation: how scientific ideas become viable products, the realities of developing breakthrough health technologies, and the challenges of translating innovation into real-world impact.
The conversation goes behind the scenes of the innovation journey — unpacking the scientific unknowns, commercial pressures and collaboration required to bring advanced diagnostic technologies to market.
But the episode also explores a bigger question at the heart of the series:
Why do so many promising innovations struggle to bridge the gap between research and reality?
From universities and partnerships to commercial strategy and the “translation gap” between science and business, this episode offers an honest look at what it takes to turn innovation into impact.
","author_name":"Professor Matt Freeman"}